Lite Strategy Employee Directory

Lite Strategy has 11-50 employees.

Employees by Department

Departments

Number of employees

Operations

2

Finance

1

C-Suite

1

Human Resources

1

Medical & Health

1

Key Employees of Lite Strategy

  • Anne Frese, Chief People Officer at Lite Strategy
    Anne Frese

    Chief People Officer

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

Lite Strategy Global Presence

globalPresence illustration
North America11-50
South America1-10

Index of contact profiles from Lite Strategy

Hundreds of professionals searching for Lite Strategy have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at Lite Strategy

Explore people who held key positions, contributed to Lite Strategy's success, and advanced their careers.

Frequently Asked Questions Regarding Lite Strategy Employees

How many employees does Lite Strategy have?
Lite Strategy has 11-50 employees
Who are Lite Strategy key employees?
Some of Lite Strategy key employees are Anne Frese
How do I contact Lite Strategy?
Lite Strategy Contact Info: Website: www.litestrategy.com
What does Lite Strategy do?

Lite Strategy Inc is a publicly traded company headquartered in San Diego, California, trading on NASDAQ under the ticker symbol LITS. Formerly known as MEI Pharma Inc, the company rebranded to Lite Strategy Inc in September 2025, reflecting its strategic transformation into the world's largest Litecoin Treasury Company and the first United States... publicly traded company to adopt Litecoin as its primary reserve asset. The company's core business model focuses on pioneering institutional-grade digital asset treasury strategies, accumulating and managing Litecoin holdings through active treasury management with the goal of concentrating LTC holdings per share as the ultimate metric of shareholder value. In August 2025, Lite Strategy acquired 929,548 Litecoin tokens for approximately 100 million dollars, establishing itself as a leader in corporate cryptocurrency treasury strategies. The company operates in partnership with GSR, a global leader in digital asset capital markets, which serves as both strategic advisor and digital asset treasury manager, providing liquidity, risk management, and strategic insight to support Litecoin adoption as a core treasury asset. Litecoin creator Charlie Lee serves as a board member, bringing expertise and credibility to the company's digital asset strategy. In addition to its digital asset treasury operations, Lite Strategy maintains a clinical-stage pharmaceutical portfolio that includes voruciclib, an oral cyclin-dependent kinase 9 inhibitor, and zandelisib, an oral selective PI3K inhibitor, both being developed as novel cancer therapies intended to improve outcomes for patients. The company's approach to oncology drug development involves evaluating drug candidates in combination with standard-of-care therapies to overcome known resistance mechanisms and address clear medical needs. Lite Strategy is led by Acting CEO and CFO Jay File and positions itself as providing investors the only United States publicly traded vehicle to gain institutional exposure to Litecoin for ...Read More

Is Lite Strategy a public company?
Lite Strategy is private company therefore does not currently have an official ticker symbol
See more information about Lite Strategy Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.